Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

Resmed (RMD) plans to release first-quarter fiscal 2027 financial and operational results on October 29, 2026, after the NYSE closes.

Rhea-AI Impact

(Neutral)

Rhea-AI Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Rhea-AI Summary

Resmed (RMD) plans to release first-quarter fiscal 2027 financial and operational results on October 29, 2026, after the NYSE closes. Management will then discuss the results in a webcast at 1:30 p.m. PT / 4:30 p.m. ET. The webcast will be accessible only through the company’s investor relations website, with a replay available approximately two hours afterward.

Key Figures

Earnings report date: October 29, 2026

Earnings report date: October 29, 2026; First quarter fiscal 2027 results, after the NYSE close

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

10/01/2026 - 04:05 PM

SAN DIEGO, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the first quarter of fiscal year 2027 on Thursday, October 29, 2026, after the New York Stock Exchange closes. Following the release, Resmed management will host a webcast to discuss the results. Other forward-looking and material information may also be discussed during the webcast.

Earnings webcast details:

Location: https://investor.resmed.com
Date: Thursday, October 29, 2026
Time: 1:30 p.m. PT / 4:30 p.m. ET
International: London, Thursday, October 29, 2026, 8:30 p.m. GMT

Sydney, Friday, October 30, 2026, 7:30 a.m. AEDT

Please note, Resmed does not use outside phone lines to access the earnings call, the call is accessible via the above webcast link only.

A replay of the earnings webcast will be accessible on Resmed’s investor relations website and available approximately two hours after the webcast. In addition, a phone replay will be available approximately three hours after the webcast and will be accessible from October 29, 2026, until November 12, 2026, at:

U.S.: +1 877.660.6853
International: +1 201.612.7415
Conference ID: 13762822

About Resmed
Resmed (NYSE: RMD, ASX: RMD) creates life-changing health technologies that people love. We’re relentlessly committed to pioneering innovative technology to empower millions of people in 140 countries to live happier, healthier lives. Our AI-powered digital health solutions, cloud-connected devices and intelligent software make home healthcare more personalized, accessible and effective. Ultimately, Resmed envisions a world where every person can achieve their full potential through better sleep and breathing, with care delivered in their own home. Learn more about how we’re redefining sleep health at Resmed.com and follow @Resmed.